Gaudium IVF and Women Health MD, chairman, board of directors and AGM
NSE: GAUDIUMIVFBSE: 544709Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹93.83.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹670 Cr1,660th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 4.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Feb 2026
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,63,97552.9% delivered
Gaudium IVF and Women Health board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.
- Chairperson and managing directorDr. Manika KhannaRelated to the promoter
- Company Secretary and Compliance OfficerNaveen Kumar
6 directors3 independent2 executive1 non-executive
- Dr. Manika Khanna · Chairperson and managing directorExecutive · joined Mar 2015 · reappointed Sep 2024 · 1 listed board · 2 committee seats
- Peeyush KhannaExecutive · joined Mar 2015 · reappointed Dec 2024 · 1 listed board
- Vishad KhannaNon-executive · joined Aug 2024 · 1 listed board · 1 committee seat, 1 as chair
- Brajesh Singh BhadauriaIndependent · joined Sep 2024 · reappointed Sep 2024 · 21 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Suresh MarpuIndependent · joined Nov 2024 · reappointed Nov 2024 · 19 months as independent · 3 listed boards · 3 as independent · 3 committee seats
- Rajesh Chunilal BhojaniIndependent · joined Jan 2025 · reappointed Jan 2025 · 17 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 25 Jun 20265 of 6 present3 independent · 27 days in between
- 28 May 20265 of 6 present3 independent · 70 days in between
- 18 Mar 20266 of 6 present3 independent · 20 days in between
- 25 Feb 20266 of 6 present3 independent · 5 days in between
2 earlier meetings
- 19 Feb 20266 of 6 present3 independent · 5 days in between
- 13 Feb 20266 of 6 present3 independent
Audit Committee
Chair Brajesh Singh Bhadauria
Rajesh Chunilal Bhojani, Suresh Marpu, Dr. Manika Khanna
- 28 May 20264 of 4 present3 independent
- 18 Mar 20264 of 4 present3 independent · 56 days in between
- 20 Jan 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Suresh Marpu
Brajesh Singh Bhadauria, Rajesh Chunilal Bhojani, Vishad Khanna
- 28 May 20264 of 4 present3 independent · 70 days in between
- 18 Mar 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Vishad Khanna
Suresh Marpu, Dr. Manika Khanna
- 18 Mar 20263 of 3 present1 independent
Risk Management Committee
Chair Dr. Manika Khanna
Vishad Khanna, Suresh Marpu
- 18 Mar 20263 of 3 present1 independent
Corporate Social Responsibility Committee
Chair Dr. Manika Khanna
Vishad Khanna, Suresh Marpu
- 28 May 20263 of 3 present1 independent · 70 days in between
- 18 Mar 20263 of 3 present1 independent
IPO Committee
- 11 Feb 20262 of 2 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- S K G N & Associates LLPPeer-review certificate valid to Dec 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gaudium IVF and Women Health AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gaudium IVF and Women Health share news and announcements
Annual general meeting, 28 Sep 2026
24,364 shareholders on the register on 21 Sep 2026; present: 3 promoters and 73 others; votes counted by SURESH CHANDRA NAINWAL / M/S. SURESH NAINWAL & COMPANY, PRACTICING COMPANY SECRETARIES.The company's voting result (opens in a new tab)
To receive, consider and adopt: a. the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and Auditor's thereon; and b. the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of Auditor's thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 74.75% · promoters 99.99% · institutions 0.30% · other public 13.68%
- To appoint a director in place of Mr. Vishad Khanna (DIN: 10729610) Non-Executive Director, who retires by rotation and being eligible, offers himself for re-appointment.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 74.75% · promoters 99.99% · institutions 0.30% · other public 13.68%
- To consider and approve the revision in the remuneration payable to Dr. Peeyush Khanna (DIN: 07091422), Whole-Time Director of the Company.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 74.75% · promoters 99.99% · institutions 0.30% · other public 13.68%
- To ratify and approve the remuneration paid/payable to Dr. Manika Khanna (DIN: 07090907), Chairperson and Managing Director of the Company.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 74.75% · promoters 99.99% · institutions 0.30% · other public 13.68%
- Appointment of M/s. Suresh Nainwal & Company, Practicing Company Secretaries as the Secretarial Auditors of the Company for a period of five (5) consecutive yearsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 74.75% · promoters 99.99% · institutions 0.30% · other public 13.68%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesFeb 2026, checked by Infomerics Valuation and Rating Limited | 90.00 | Funding capital expenditure towards establishment of New IVF Centres of the Company | 50.00 | 1.03 | No |
| Public IssuesFeb 2026, checked by Infomerics Valuation and Rating Limited | 90.00 | Repayment / pre-payment, in full or in part, of certain outstanding borrowings availed by the Company | 20.00 | 18.07 | No |
| Public IssuesFeb 2026, checked by Infomerics Valuation and Rating Limited | 90.00 | General Corporate Purposes (GCP)* | 12.28 | 7.21 | No |